Search research articles
Contact Us
Filters
Showing results (31-40 of 506) with videos related to
Page
of 51
Sort By:
Leukemia & Lymphoma
|
June 3, 2014
Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data
Antonio Palumbo, Massimo Offidani, Francesca Patriarca, et al.
International Journal of Molecular Sciences
|
September 19, 2020
A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
Darina Ocadlikova, Clara Iannarone, Anna Rita Redavid, et al.
Hematological Oncology
|
July 24, 2019
Spontaneous remission of follicular lymphoma
Alice Morigi, Beatrice Casadei, Lisa Argnani, et al.
European Journal of Haematology
|
August 13, 2017
Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study
Evangelos Terpos, Marco Gobbi, Anna Potamianou, et al.
Leukemia Research
|
April 17, 2026
An Italian Delphi consensus on the current and future burden and clinical management of lenalidomide-refractory multiple myeloma
Paolo Corradini, Pellegrino Musto, Carlotta Galeone, et al.
Cancer Genetics
|
January 3, 2022
t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities
Carmen Baldazzi, Simona Luatti, Giulia Marzocchi, et al.
Expert Opinion on Biological Therapy
|
December 9, 2024
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma
Katia Mancuso, Simona Barbato, Marco Talarico, et al.
Expert Review of Hematology
|
October 3, 2013
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors
Gabriele Gugliotta, Fausto Castagnetti, Miriam Fogli, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
January 3, 2015
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
Enrica Borsi, Carolina Terragna, Annamaria Brioli, et al.
Translation (Austin, Tex.)
|
January 30, 2016
Cap dependent translation contributes to resistance of myeloma cells to bortezomib
Marilena Mancino, Stefano Grosso, Carolina Terragna, et al.
Page
of 51
Search research articles
Search
Showing results (31-40 of 506) with videos related to
Sort By:
Page
of 51
Leukemia & Lymphoma
|
June 3, 2014
Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data
Antonio Palumbo, Massimo Offidani, Francesca Patriarca, et al.
International Journal of Molecular Sciences
|
September 19, 2020
A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
Darina Ocadlikova, Clara Iannarone, Anna Rita Redavid, et al.
Hematological Oncology
|
July 24, 2019
Spontaneous remission of follicular lymphoma
Alice Morigi, Beatrice Casadei, Lisa Argnani, et al.
European Journal of Haematology
|
August 13, 2017
Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study
Evangelos Terpos, Marco Gobbi, Anna Potamianou, et al.
Leukemia Research
|
April 17, 2026
An Italian Delphi consensus on the current and future burden and clinical management of lenalidomide-refractory multiple myeloma
Paolo Corradini, Pellegrino Musto, Carlotta Galeone, et al.
Cancer Genetics
|
January 3, 2022
t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities
Carmen Baldazzi, Simona Luatti, Giulia Marzocchi, et al.
Expert Opinion on Biological Therapy
|
December 9, 2024
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma
Katia Mancuso, Simona Barbato, Marco Talarico, et al.
Expert Review of Hematology
|
October 3, 2013
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors
Gabriele Gugliotta, Fausto Castagnetti, Miriam Fogli, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
January 3, 2015
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
Enrica Borsi, Carolina Terragna, Annamaria Brioli, et al.
Translation (Austin, Tex.)
|
January 30, 2016
Cap dependent translation contributes to resistance of myeloma cells to bortezomib
Marilena Mancino, Stefano Grosso, Carolina Terragna, et al.
Page
of 51